In general, semaglutide (Wegovy ) and tirzepatide (Zepbound ) are FDA-approved for weight loss in people with: A BMI of 30 or higher , or A BMI of 27 or higher with at least one weight-related condition, like type 2 diabetes or high blood pressure Each medication also has additional FDA-approved uses beyond weight loss: Wegovy is also approved to reduce the risk of major cardiovascular events like heart attack and stroke in adults with cardiovascular disease
The field has evolved from the 2-minute half-life of native GLP-1 to engineered analogs that persist for a week a 5,000-fold improvement achieved through fatty acid conjugation, D-amino acid substitution, cyclization, and depot formulations
The drug mimics the GLP-1 hormone, released after a meal, which helps curb appetite and slows foods passage through the stomach
The plate formula Half your plate: lean protein
Sorry - I looked from the top
The reality is, it's probably all true on some level, and the overall perception of GLP-1 Tongue is a combination of these effects